FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002933895> ?p ?o ?g. }

• W2002933895 endingPage "2758" @default.
• W2002933895 startingPage "2747" @default.
• W2002933895 abstract "Cholecystokinin (CCK) is a rapidly degraded gastrointestinal peptide that stimulates satiety and insulin secretion. We aimed to investigate the beneficial weight-lowering and metabolic effects of the novel N-terminally modified CCK analogue, (pGlu-Gln)-CCK-8.The biological actions of (pGlu-Gln)-CCK-8 were comprehensively evaluated in pancreatic clonal BRIN BD11 cells and in vivo in high-fat-fed and ob/ob mice.(pGlu-Gln)-CCK-8 was completely resistant to enzymatic degradation and its satiating effects were significantly (p < 0.05 to p < 0.001) more potent than CCK-8. In BRIN-BD11 cells, (pGlu-Gln)-CCK-8 exhibited enhanced (p < 0.01 to p < 0.001) insulinotropic actions compared with CCK-8. When administered acutely to high-fat-fed or ob/ob mice, (pGlu-Gln)-CCK-8 improved glucose homeostasis. Sub-chronic twice daily injections of (pGlu-Gln)-CCK-8 in high-fat-fed mice for 28 days significantly decreased body weight (p < 0.05 to p < 0.001), accumulated food intake (p < 0.05 to p < 0.001), non-fasting glucose (p < 0.05) and triacylglycerol deposition in pancreatic (p < 0.01), adipose (p < 0.05) and liver (p < 0.001) tissue, and improved oral (p < 0.05) and i.p. (p < 0.05) glucose tolerance and insulin sensitivity (p < 0.001). Similar observations were noted in ob/ob mice given twice daily injections of (pGlu-Gln)-CCK-8. In addition, these beneficial effects were not reproduced by simple dietary restriction and were not associated with changes in energy expenditure. There was no evidence for development of tolerance to (pGlu-Gln)-CCK-8, and analysis of histology or blood-borne markers for pancreatic, liver and renal function in mice treated with (pGlu-Gln)-CCK-8 suggested little abnormal pathology.These studies emphasise the potential of (pGlu-Gln)-CCK-8 for the alleviation of obesity and insulin resistance." @default.
• W2002933895 created "2016-06-24" @default.
• W2002933895 creator A5001545372 @default.
• W2002933895 creator A5006863322 @default.
• W2002933895 creator A5015582237 @default.
• W2002933895 creator A5061926350 @default.
• W2002933895 creator A5075620817 @default.
• W2002933895 creator A5084803852 @default.
• W2002933895 date "2012-07-20" @default.
• W2002933895 modified "2023-09-27" @default.
• W2002933895 title "Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK-8 in mouse models of obesity/diabetes" @default.
• W2002933895 cites W1523326709 @default.
• W2002933895 cites W1574114123 @default.
• W2002933895 cites W1598367285 @default.
• W2002933895 cites W1724200113 @default.
• W2002933895 cites W1970632332 @default.
• W2002933895 cites W1971463295 @default.
• W2002933895 cites W1976990619 @default.
• W2002933895 cites W1983092748 @default.
• W2002933895 cites W1984170856 @default.
• W2002933895 cites W1985621101 @default.
• W2002933895 cites W1989188472 @default.
• W2002933895 cites W1994325349 @default.
• W2002933895 cites W2013665956 @default.
• W2002933895 cites W2018686602 @default.
• W2002933895 cites W2025507241 @default.
• W2002933895 cites W2031079527 @default.
• W2002933895 cites W2033423680 @default.
• W2002933895 cites W2036465362 @default.
• W2002933895 cites W2054107609 @default.
• W2002933895 cites W2059716194 @default.
• W2002933895 cites W2064445900 @default.
• W2002933895 cites W2064810028 @default.
• W2002933895 cites W2081081330 @default.
• W2002933895 cites W2085993091 @default.
• W2002933895 cites W2105766689 @default.
• W2002933895 cites W2109671400 @default.
• W2002933895 cites W2145965925 @default.
• W2002933895 cites W2159172675 @default.
• W2002933895 cites W2163157908 @default.
• W2002933895 cites W2169274492 @default.
• W2002933895 cites W2579688957 @default.
• W2002933895 cites W4237117054 @default.
• W2002933895 cites W4249731957 @default.
• W2002933895 doi "https://doi.org/10.1007/s00125-012-2654-6" @default.
• W2002933895 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22814764" @default.
• W2002933895 hasPublicationYear "2012" @default.
• W2002933895 type Work @default.
• W2002933895 sameAs 2002933895 @default.
• W2002933895 citedByCount "53" @default.
• W2002933895 countsByYear W20029338952012 @default.
• W2002933895 countsByYear W20029338952013 @default.
• W2002933895 countsByYear W20029338952014 @default.
• W2002933895 countsByYear W20029338952015 @default.
• W2002933895 countsByYear W20029338952016 @default.
• W2002933895 countsByYear W20029338952017 @default.
• W2002933895 countsByYear W20029338952018 @default.
• W2002933895 countsByYear W20029338952019 @default.
• W2002933895 countsByYear W20029338952020 @default.
• W2002933895 countsByYear W20029338952021 @default.
• W2002933895 countsByYear W20029338952022 @default.
• W2002933895 countsByYear W20029338952023 @default.
• W2002933895 crossrefType "journal-article" @default.
• W2002933895 hasAuthorship W2002933895A5001545372 @default.
• W2002933895 hasAuthorship W2002933895A5006863322 @default.
• W2002933895 hasAuthorship W2002933895A5015582237 @default.
• W2002933895 hasAuthorship W2002933895A5061926350 @default.
• W2002933895 hasAuthorship W2002933895A5075620817 @default.
• W2002933895 hasAuthorship W2002933895A5084803852 @default.
• W2002933895 hasBestOaLocation W20029338951 @default.
• W2002933895 hasConcept C126322002 @default.
• W2002933895 hasConcept C134018914 @default.
• W2002933895 hasConcept C170493617 @default.
• W2002933895 hasConcept C171089720 @default.
• W2002933895 hasConcept C185592680 @default.
• W2002933895 hasConcept C2777391703 @default.
• W2002933895 hasConcept C2777593968 @default.
• W2002933895 hasConcept C2777951760 @default.
• W2002933895 hasConcept C2778938600 @default.
• W2002933895 hasConcept C2779306644 @default.
• W2002933895 hasConcept C3018667095 @default.
• W2002933895 hasConcept C555293320 @default.
• W2002933895 hasConcept C56191518 @default.
• W2002933895 hasConcept C71924100 @default.
• W2002933895 hasConceptScore W2002933895C126322002 @default.
• W2002933895 hasConceptScore W2002933895C134018914 @default.
• W2002933895 hasConceptScore W2002933895C170493617 @default.
• W2002933895 hasConceptScore W2002933895C171089720 @default.
• W2002933895 hasConceptScore W2002933895C185592680 @default.
• W2002933895 hasConceptScore W2002933895C2777391703 @default.
• W2002933895 hasConceptScore W2002933895C2777593968 @default.
• W2002933895 hasConceptScore W2002933895C2777951760 @default.
• W2002933895 hasConceptScore W2002933895C2778938600 @default.
• W2002933895 hasConceptScore W2002933895C2779306644 @default.
• W2002933895 hasConceptScore W2002933895C3018667095 @default.
• W2002933895 hasConceptScore W2002933895C555293320 @default.
• W2002933895 hasConceptScore W2002933895C56191518 @default.
• W2002933895 hasConceptScore W2002933895C71924100 @default.

• next